282
Participants
Start Date
May 10, 2013
Primary Completion Date
May 7, 2016
Study Completion Date
May 16, 2016
BBI608
Placebo
Best Supportive Care
Bankstown/ Lidcombe, Bankstown
Peter MacCallum Cancer Institute, East Melbourne
Townsville Hospital, Douglas
The Queen Elizabeth Hospital, Woodville South
Flinders Medical Centre, Bedford Park
Lyell McEwin Hospital, Elizabeth Vale
St John of God - Subiaco, Subiaco
St John of God Bunbury Hospital, Bunbury
Royal Hobart Hospital, Hobart
Tom Baker Cancer Centre, Calgary
Cross Cancer Institute, Edmonton
BCCA - Abbotsford Centre, Abbotsford
BCCA - Cancer Centre for the Southern Interior, Kelowna
BCCA - Fraser Valley Cancer Centre, Surrey
BCCA - Vancouver Cancer Centre, Vancouver
BCCA - Vancouver Island Cancer Centre, Victoria
CancerCare Manitoba, Winnipeg
Horizon Health Network,, Fredericton
The Moncton Hospital, Moncton
The Vitalite Health Network - Dr. Leon Richard, Moncton
Atlantic Health Sciences Corporation, Saint John
Dr. H. Bliss Murphy Cancer Centre, St. John's
QEII Health Sciences Centre, Halifax
The Royal Victoria Hospital, Barrie
Health Sciences North, Greater Sudbury
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
London Regional Cancer Program, London
Credit Valley Hospital, Mississauga
Lakeridge Health Oshawa, Oshawa
Ottawa Hospital Research Institute, Ottawa
Algoma District Cancer Program, Sault Ste. Marie
Niagara Health System, St. Catharines
Thunder Bay Regional Health Science Centre, Thunder Bay
Toronto East General Hospital, Toronto
Odette Cancer Centre, Toronto
St. Michael's Hospital, Toronto
Mount Sinai Hospital, Toronto
Univ. Health Network-Princess Margaret Hospital, Toronto
Hopital de la Cite-de-la-Sante, Laval
L'Hotel-Dieu de Levis, Lévis
CHUM - Hopital Notre-Dame, Montreal
McGill University - Dept. Oncology, Montreal
CHUQ-Pavillon Hotel-Dieu de Quebec, Québec
CHA-Hopital Du St-Sacrement, Québec
Centre hospitalier universitaire de Sherbrooke, Sherbrooke
Centre hospitalier regional de Trois-Rivieres, Trois-Rivières
Allan Blair Cancer Centre, Regina
Saskatoon Cancer Centre, Saskatoon
Chiba Cancer Center, Chiba
National Kyushu Cancer Center, Fukuoka
National Cancer Center Hospital East, Kashiwa
Kobe City Medical Center General Hospital, Kobe
National Hospital Organization Shikoku Cancer Center, Matsuyama
Kyorin University Hospital, Mitaka
Aichi Cancer Center Hospital, Nagoya
Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka
Saitama Prefectural Cancer Center, Saitama
Hokkaido University Hospital, Sapporo
Shizuoka Cancer Center, Shizuoka
Osaka Medical College Hospital, Takatsuki
Cancer Institute Hospital of JFCR, Tokyo
Keio University Hospital, Tokyo
National Cancer Center Hospital, Tokyo
Lead Sponsor
Sumitomo Pharma America, Inc.
INDUSTRY
NCIC Clinical Trials Group
NETWORK